First two medicinal products to undergo EU joint clinical assessments announced
On 16 April 2025, the European Commission (EC) published a press release announcing the launch of and details regarding the…
On 16 April 2025, the European Commission (EC) published a press release announcing the launch of and details regarding the…
On 1 January 2025, important legal amendments relating to drug pricing in Germany that were included in the Medical Research…
Germany’s Federal Ministry of Health has published its evaluation report on the impact of the GKV Financial Stabilization Act on…
The large amendment to Poland’s Reimbursement Act (Duża Nowelizacja Ustawy Refundacyjnej, DNUR) finally came into legal force on November 1,…
A unified system of European patents has been a goal of those working towards European integration since before the establishment…
On 14 September, the Czech Chamber of Deputies gave its final approval to the amendment of the Public Health Insurance…
Pharmaceutical pricing is increasingly becoming a broader topic in the global push towards sustainability and environmental, social, and government (ESG)…
Poland's pricing and reimbursement system has always had a reputation for restrictiveness when it comes to originator therapies, with its…
Fixed prices for prescription medicines are an important part of the framework of pharmaceutical pricing and reimbursement regulation in Germany.…
Earlier this year, important amendments to of Ordinance 10 (on the terms and procedure for the payment of medicinal products)…